Project Grant HT94252410366
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$272K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This $961,118 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Johns Hopkins University to target gut bacterial androgen production in order to reverse abiraterone resistance in metastatic prostate cancer. The 3-year award, beginning September 1, 2024, will enable the university to conduct innovative scientific studies aimed at developing treatments to improve health outcomes for military...
This federal Project Grant award, ID HT94252410076, was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to The Johns Hopkins University. The $163,750 award, granted on February 1, 2024, will support research examining the influence of the gut microbiome on drug metabolism and treatment resistance in prostate cancer, with a completion date of January 31, 2026. As a leading research institution, The Johns Hopkins...
The Johns Hopkins University will provide research services totaling $1,216,646 under a Project Grant award from the Defense Health Agency. The award's stated purpose is to investigate the role of polyamine metabolism in advanced prostate cancer. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care. Specifically, the program aims to develop medical solutions for battlefield...
This $1,473,751 federal Project Grant award, issued on August 15, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University to investigate the influence of the tumor immune microenvironment and microbiome on prostate cancer immunotherapy response in Black men. The 3-year research initiative aims to transform healthcare through innovative and impactful medical research focused...
The Department of the Army Medical Command awarded The Johns Hopkins University a $232,878 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "EXPLORING THE ROLE OF EPITRANSCRIPTOMICS IN THE EVOLUTION OF NEUROENDOCRINE PROSTATE CANCER," will fund research to investigate innovative approaches to understanding, diagnosing, and treating prostate cancer, with a focus on military personnel and veterans. The two-year grant...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) in the amount of $1,972,922.00 provides funding to The Johns Hopkins University for research on "THERAPEUTIC TARGETING OF TREM2-POSITIVE TUMOR-ASSOCIATED MACROPHAGES WITHIN THE TUMOR MICROENVIRONMENT OF LETHAL PROSTATE CANCER TO REDUCE HEALTH DISPARITIES." The research aims to investigate innovative approaches to the prevention,...
The Johns Hopkins University was awarded a $1,228,125 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research titled "PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY" from September 2021 through September 2024. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This $484,013 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of "PSMA-TARGETED MULTIPARAMETRIC ULTRASOUND" research at The Johns Hopkins University. The award period runs from August 1, 2024 to July 31, 2026. The project aims to advance biomedical research and innovative medical solutions relevant to military personnel and the broader public. As a leading research institution, The...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $459,932 to The Johns Hopkins University to conduct research on "INTERROGATING CRIBRIFORM LESIONS TO UNCOVER MECHANISMS OF PROSTATE CANCER AGGRESSIVENESS AND METASTASIS". The two-year project aims to investigate innovative approaches to understanding and treating prostate cancer, with a focus on examining the biological...
This $1,406,799 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research to develop real-time localization techniques using near-infrared fluorophores to guide robotic-assisted radical prostatectomy procedures. The 3-year award, running from August 1, 2024 to July 31, 2027, will enable Johns Hopkins to conduct innovative biomedical research to improve surgical outcomes and...